| White Papers
|
Global Bioanalytical Services |
A High Sensitivity Dual Solid Phase Extraction LC-MS/MS Assay for the Determination of the Therapeutic Peptide Desmopressin in Human Plasma |
Lars Neudert, Markus Zaugg, Petra Struwe, Simon Wood |
| White Papers
|
Global Clinical Research |
A TFC MS/MS Method for the Determination of the Cholinesterase Sensitive Analyte Rivastigmine in Human Plasma |
Lars Neudert, Laurence Meunier, Petra Struwe, Simon Wood, Werner Meyer |
| White Papers
|
Global Bioanalytical Services |
Assessment of Extract Cleanliness Using Different On-Line Clean Up Selectivities for a Turbulent Flow Chromatography (TFC) – MS/MS Method for the Determination of a Common Decongestant Agent in Human Plasma |
Lars Neudert, Petra Struwe, Simon Wood |
| White Papers
|
Drug Development Services |
Evaluation of Male Reproductive Safety During Clinical Development |
Malle Jurima-Romet |
| White Papers
|
Drug Development Services |
Biomarkers – Unlocking Value in Early Drug Development |
Malle Jurima-Romet |
| White Papers
|
Global Bioanalytical Services |
Validation of an LC-MS/MS Method for the Determination of Ribavirin in Human Plasma (EDTA) |
Corey Ohnmacht, Curtis Sheldon, Erica Nachi, Jason Wenzl |
| White Papers
|
Global Bioanalytical Services |
Method Validation of an LC-MS/MS Method for the Determination of Gemcitabine and 2′-deoxy-2′, 2′Difluorouridine (dFdU) in Tetrahydrouridine (THU)-Treated Plasma |
Brandon Retke, Corey Ohnmacht, Curtis Sheldon, Elizabeth Peterson, Erica Nachi |
| White Papers
|
Drug Development Services, Global Clinical Research |
Managing Clinical Trial Application (CTA) Acceptability to Support Phase I Clinical Studies in the United Kingdom |
Fiona McNeilly, Heimo Scheer, Sarah Roberts |
| White Papers
|
Global Clinical Research |
Highly Automated ECG Analysis |
Joy Olbertz, William Wheeler |
| White Papers
|
Global Bioanalytical Services |
The Development and Validation of Two High Through-Put Methods for the Determination of Biomarkers IFG-1 and IGFBP-3 in Human Plasma |
Curtis Sheldon, Richard Sukovaty, Sarah Roby-Peters |
| White Papers
|
Clinical Pharmacology Sciences, Drug Development Services |
Determining the Preclinical Toxicokinetic Comparability for a Biosimilar Drug |
Anita O'Connor, David Goblot, Elliot Offman |
| White Papers
|
Clinical Pharmacology Sciences |
How Modeling and Simulation Can Help in Obtaining More Information from a QT/QTc Study |
Julie Grenier |
| See More ↓ |